We sought to detect a depletion of RAD51 in NPC cells treated with Abexinostat as previously reported for the human colonic carcinoma cells HCT116 and multiple myeloma cell lines treated by HDAC inhibitors [29], [30]. The gene discussed is RAD51; the disease is nasopharyngeal carcinoma.